Skip to content

Safety Evaluation of Long-term Intake of Powdered Tea in adult male and female.

Safety Evaluation of Long-term Intake of Powdered Tea in adult male and female. - Safety Evaluation of Long-term Intake of Powdered Tea in adult male and female.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020767
Enrollment
20
Registered
2016-01-27
Start date
2016-01-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Consumption of powdered tea, quantity of recommended daily intake, for 12 weeks

Sponsors

TTC CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females from 20 to 64 years of age 2) Subjects falling under any of the following A. fasting blood glucose levels are less than 110 mg/dL or 2-hour glucose levels in 75 g OGTT are less than 140 mg/dL (about 10 subjects) B. fasting blood glucose levels are ranged 110 to 125 mg/dL or 2-hour glucose levels in 75 g OGTT are ranged 140 to 199 mg/dL (about 10 subjects)

Exclusion criteria

Exclusion criteria: (1) Subjects having a current or past history of serious diseases such as diabetes, hepatic or renal disorder, or cardiovascular disease (2) Subjects having possibilities for emerging allergy related to the study (3) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (4) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (5) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (6) Subjects who intend to become pregnant or lactating (7) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (8) Subjects judged as unsuitable for the study by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Hematologic test Blood biochemistry test Urine test Blood pressure/pulsation Weight/body mass index Medical Interview Adverse event

Countries

Japan

Contacts

Public ContactShinsuke Tsuji

TTC CO., LTD. Clinical Research Planning Department

s.tsuji@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026